Lord Moylan : To ask His Majesty's Government what policy objectives they have set for Great British Railways, and in what order of priority these objectives have been ranked. Minister of State, Department for Transport (Lord Hendy of Richmond Hill, CBE) : Clause 3 of the Railway’s Bill sets out the statutory functions of GBR – what we expect it to do, and Clause 18 its general duties – what we expect it to consider when it is delivering on its functions. Taken together, the

Lord Moylan : To ask His Majesty's Government what estimates they have made of the level of Government support to the rail sector per passenger journey in (1) 2024–25, (2) 2025–26, (3 ) 2026–27, (4) 2027–28, and (5) 2028–29. (HL14612) Minister of State, Department for Transport (Lord Hendy of Richmond Hill, CBE) : The Department for Transport's support for the 14 contracted operators and Network Rail was £8.47 per journey in 2024/25. It is currently estimated that this will

Lord Moylan : To ask His Majesty's Government what has been the total expenditure on the maintenance of the rail network in each of the past six financial years; and what proportion this expenditure represented of total Network Rail expenditure for each of those years. Minister of State, Department for Transport (Lord Hendy of Richmond Hill, CBE) : The table below shows the total expenditure on the maintenance of the rail network in the past six financial years and its propor

Lord Moylan : To ask His Majesty's Government what treatments exist for those mantle cell lymphoma patients unable to access allogeneic stem cell transplants due to (1) ethnicity, (2) age, and (3) ethnicity and age. Parliamentary Under Secretary of State, Department of Health and Social Care (Lady Merron) : A number of National Health Service treatment options are available for patients with mantle cell lymphoma, and may include: - chemotherapy plus rituximab; - autologous s

Lord Moylan : To ask His Majesty's Government what safeguards exist to prevent patients from losing access to established, life-extending cancer treatments as a result of changes to NICE methodology. Parliamentary Under Secretary of State, Department of Health and Social Care (Lady Merron) : The National Institute for Health and Care Excellence (NICE) evaluates all newly licensed cancer medicines and may recommend promising treatments for use through the Cancer Drugs Fund (C

Lord Moylan : To ask His Majesty's Government what assessment they have made of the impact on patients of withdrawing access to an existing cancer treatment, namely CAR-T therapy for relapsed or refractory mantle cell lymphoma, which has been available on the NHS since 2021. Lord Moylan : To ask His Majesty's Government how many patients have received CAR-T therapy for mantle cell lymphoma via the Cancer Drugs Fund; and what assessment has been made of the clinical outcomes f

Lord Moylan : To ask His Majesty's Government what assessment they have made of the availability of specialist rail plant used in the maintenance of the rail network. Minister of State, Department for Transport (Lord Hendy of Richmond Hill, CBE) : Network Rail is responsible for assessing the availability of specialist rail plant used in maintaining the rail network. It is currently reviewing its long-term equipment requirements for track maintenance and renewals, to ensure t

Lord Moylan : To ask His Majesty's Government what estimate they have made of the capital and ongoing operating costs of developing, launching and maintaining the proposed Great British Railways ticketing website and mobile application. Minister of State, Department for Transport (Lord Hendy of Richmond Hill, CBE) : Officials continue to develop the proposition for the Great British Railways app and website. We are engaging with industry on this project and will provide upda